No profile data available.
Nexalin Technology, Inc. (NXL) is a healthcare company in the targeted healthcare equipment industry, based in Houston, United States, with about 6 full-time employees.
It reported revenue of $301,647 for fiscal year 2025, up 78.8% from fiscal year 2024, and net income of -$8.22 million. China was its largest region in fiscal year 2025, with 63% of revenue. Its market capitalization was $17.96 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China.
Nexalin Technology reported $301,647 in revenue for fiscal year 2025, up 78.8% from $168,721 in fiscal year 2024.
China: 63% of revenue by region in fiscal year 2025, followed by United States (37%).
$17.96 million as of December 4, 2025.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include InspireMD, Inc. (NSPR), SeaStar Medical Holding Corporation (ICU), Firefly Neuroscience, Inc. (AIFF), Guided Therapeutics, Inc. (GTHP).